Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 2
2007 1
2008 1
2009 8
2010 14
2011 7
2012 6
2013 7
2014 4
2015 1
2017 3
2018 3
2019 6
2020 5
2021 2
2022 4
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics.
Murugaiyan J, Kumar PA, Rao GS, Iskandar K, Hawser S, Hays JP, Mohsen Y, Adukkadukkam S, Awuah WA, Jose RAM, Sylvia N, Nansubuga EP, Tilocca B, Roncada P, Roson-Calero N, Moreno-Morales J, Amin R, Kumar BK, Kumar A, Toufik AR, Zaw TN, Akinwotu OO, Satyaseela MP, van Dongen MBM. Murugaiyan J, et al. Among authors: hawser s. Antibiotics (Basel). 2022 Feb 4;11(2):200. doi: 10.3390/antibiotics11020200. Antibiotics (Basel). 2022. PMID: 35203804 Free PMC article. Review.
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in central and northern Europe (Belgium, Norway, Sweden, Switzerland)-SMART 2017-21.
Karlowsky JA, Lob SH, Hawser SP, Kothari N, Siddiqui F, Alekseeva I, DeRyke CA, Young K, Motyl MR, Sahm DF. Karlowsky JA, et al. Among authors: hawser sp. JAC Antimicrob Resist. 2023 Aug 11;5(4):dlad098. doi: 10.1093/jacamr/dlad098. eCollection 2023 Aug. JAC Antimicrob Resist. 2023. PMID: 37577157 Free PMC article.
Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class.
Huang DB, Brothers KM, Mandell JB, Taguchi M, Alexander PG, Parker DM, Shinabarger D, Pillar C, Morrissey I, Hawser S, Ghahramani P, Dobbins D, Pachuda N, Montelaro R, Steckbeck JD, Urish KL. Huang DB, et al. Among authors: hawser s. PLoS One. 2022 Sep 16;17(9):e0274815. doi: 10.1371/journal.pone.0274815. eCollection 2022. PLoS One. 2022. PMID: 36112657 Free PMC article.
Meropenem-ANT3310, a unique β-lactam-β-lactamase inhibitor combination with expanded antibacterial spectrum against Gram-negative pathogens including carbapenem-resistant Acinetobacter baumannii.
Zalacain M, Achard P, Llanos A, Morrissey I, Hawser S, Holden K, Toomey E, Davies D, Leiris S, Sable C, Ledoux A, Bousquet J, Castandet J, Lozano C, Everett M, Lemonnier M. Zalacain M, et al. Among authors: hawser s. Antimicrob Agents Chemother. 2024 Mar 6;68(3):e0112023. doi: 10.1128/aac.01120-23. Epub 2024 Jan 30. Antimicrob Agents Chemother. 2024. PMID: 38289044 Free PMC article.
75 results